| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 19.6 | 12.5 |
| Profit before tax | 5.0 | -0.6 |
| Net income | 4.6 | -0.6 |
| EPS (diluted, $ a share) | $0.12 | $-0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +57.3% |
|---|---|
| Operating margin | 23.7% |
10-Q filed with the SEC, NASDAQ: FENC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Fennec Pharmaceuticals Inc.: key numbers
- Share price
- $12.76Close, Nov 16
- Market cap
- $450M
- Shares outstanding
- 35.31MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Fennec Pharmaceuticals Inc.
All →Fennec Pharmaceuticals Director Marco Maria Brughera Sells $240K of Stock
Marco Maria Brughera, Director, sold 20,000 shares of Fennec Pharmaceuticals Inc. at $12.00 a share, worth $240K in total on Nov 13, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $240K
- Shares
- 20,000
- Price
- $12.00
- Role
- Director
- Holding change
- -100.0%
- Trade date
- Nov 13, 2026
Fennec Pharmaceuticals Clinical Trial Data
Fennec Pharmaceuticals announced positive results from the investigator-initiated Phase 2 STS-J01 clinical study of PEDMARK in Japan for pediatric and AYA patients. The study met its primary endpoint, showing hearing loss in only 24.0% of patients compared to a historical benchmark of 56.4%, while demonstrating no interference with cisplatin antitumor activity.
Fennec Pharmaceuticals Director Marco Maria Brughera Sells $160K of Stock
Marco Maria Brughera, Director, sold 15,545 shares of Fennec Pharmaceuticals Inc. at $10.29 a share, worth $160K in total on Sep 15, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $160K
- Shares
- 15,545
- Price
- $10.29
- Role
- Director
- Holding change
- -100.0%
- Trade date
- Sep 15, 2026